InDex Pharmaceuticals Holding AB (publ) announced that after more than seven years as CEO, Peter Zerhouni has decided to leave his position. The company's CFO Johan Giléus has been appointed acting CEO while a new CEO is being recruited, and he will also continue as CFO. Peter Zerhouni will be available to the board during his notice period.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.518 SEK | +1.97% | -1.52% | +102.34% |
05-21 | Global markets live: Microsoft, Roche, BMW, Nintendo, Nordson... | |
05-21 | InDex Pharmaceuticals to Buy Flerie Invest Under Reverse Merger Plan | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+102.34% | 26.17M | |
+38.59% | 727B | |
-7.89% | 347B | |
+15.66% | 319B | |
+0.24% | 274B | |
+13.47% | 238B | |
+7.35% | 204B | |
-6.42% | 203B | |
+4.23% | 161B | |
-1.70% | 160B |
- Stock Market
- Equities
- INDEX Stock
- News InDex Pharmaceuticals Holding AB
- InDex Pharmaceuticals Holding AB Announces CEO Changes